News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Paolo Tarantino Honored to Receive the 2025 Yvonne ‘Top Voice’ Award Presented by OncoDaily
Paolo Tarantino/X
May 31, 2025, 04:53

Paolo Tarantino Honored to Receive the 2025 Yvonne ‘Top Voice’ Award Presented by OncoDaily

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post by Luiza Pamela Beato, Medical Oncology Resident, on X, adding:

“Receiving the Yvonne ‘Top Voice’ Award tonight was a honor. Receiving it from the hands of my first and lifelong mentor Giuseppe Curigliano – priceless. Thank you OncoDaily for this award!!!”

Quoting Luiza Pamela Beato‘s post:

“A well deserved award. Congratulations!! Paolo Tarantino.”

Yvonne 'Top Voice' Award

Read More about Yvonne Award 2025 on OncoDaily.

cancer Giuseppe Curigliano Luiza Pamela Beato OncoDaily Oncology Paolo Tarantino Yvonne 'Top Voice' Award Yvonne Award 2025
Special Coverage
Oncolibrary
Jun 1, 2025, 12:40
Results from Metacure Cohorts B2: Intensified Hormonal Blockade and SBRT for PSMA-PET Detected Oligometastatic Prostate Adenocarcinoma
Oncolibrary
Jun 1, 2025, 12:03
EV-302 Updates at ASCO 2025: Enfortumab Vedotin Plus Pembrolizumab Doubles Complete Response Rate in Advanced Urothelial Carcinoma
Oncolibrary
Jun 1, 2025, 11:55
Tagitanlimab Boosts Chemotherapy in Nasopharyngeal Cancer: Phase 3 Results at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:51
FIRE-4 Study Results: Cetuximab Re-challenge in Metastatic RAS Wild-Type Colorectal Cancer
Oncolibrary
Jun 1, 2025, 11:45
Combining Darolutamide and Goserelin: A New Frontier in Fighting Salivary Gland Cancer at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:44
SURE-02 Phase 2 Trial Interim Results: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab Shows Promising Bladder Preservation in Muscle-Invasive Bladder Cancer
Blog
Jun 1, 2025, 11:42
Estela Rodriguez: Day 2 ASCO25 Agenda
Blog
Jun 1, 2025, 11:35
Mario Balsa: Breaking from ASCO 2025 - DESTINY-Gastric04 Trial
Blog
Jun 1, 2025, 11:33
Cristiane Bergerot: Genomic Insights from IMmotion010
Oncolibrary
Jun 1, 2025, 11:24
CheckMate 901 Trial Final Results at ASCO 2025: Nivolumab + Ipilimumab Shows Durable Responses in Cisplatin-Ineligible Metastatic Urothelial Carcinoma
Blog
Jun 1, 2025, 11:07
Armando Orlandi: ASCO25 Breast Cancer Update, Early Data from May 30th Session
Oncolibrary
Jun 1, 2025, 11:05
CodeBreaK 101 trial at ASCO 2025. Sotorasib-Based Triplet Shows Durable Responses in KRAS G12C-Mutant Colorectal Cancer